Nurix Therapeutics, Inc. (NRIX)
26.14
+0.82
(+3.24%)
USD |
NASDAQ |
Sep 04, 16:00
26.13
-0.01
(-0.04%)
After-Hours: 20:00
Nurix Therapeutics Cash and Short Term Investments (Annual) : 592.94M for Nov. 30, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| November 30, 2025 | 592.94M |
| November 30, 2024 | 609.58M |
| November 30, 2023 | 287.91M |
| November 30, 2022 | 309.14M |
| Date | Value |
|---|---|
| November 30, 2021 | 295.72M |
| November 30, 2020 | 281.15M |
| November 30, 2019 | 37.72M |
| November 30, 2018 | 39.04M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Monte Rosa Therapeutics, Inc. | 377.10M |
| Gilead Sciences, Inc. | 9.613B |
| TG Therapeutics, Inc. | 141.97M |
| Cue Biopharma, Inc. | 27.14M |
| Keros Therapeutics, Inc. | 287.42M |